A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

引用本文：	Pilla L,Patuzzo R,Rivoltini L,Maio M,Pennacchioli E,Lamaj E,Maurichi A,Massarut S,Marchianò A,Santantonio C,Tosi D,Arienti F,Cova A,Sovena G,Piris A,Nonaka D,Bersani I,Di Florio A,Luigi M,Srivastava PK,Hoos A,Santinami M,Parmiani G.A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients[J].Cancer Immunology, Immunotherapy,2006,55(8):958-968.

作者姓名：	Pilla L Patuzzo R Rivoltini L Maio M Pennacchioli E Lamaj E Maurichi A Massarut S Marchianò A Santantonio C Tosi D Arienti F Cova A Sovena G Piris A Nonaka D Bersani I Di Florio A Luigi M Srivastava PK Hoos A Santinami M Parmiani G

摘要：
收稿时间：	3 August 2005
修稿时间：	27 August 2005
本文献已被 PubMed SpringerLink 等数据库收录！